MedTrace Logo

Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation

NCT04635579 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-02-28

Study results available
· View outcomes & findings →

Summary

This is a cross-sectional study on the use of personalized blood flow restriction during rehabilitation exercises and its effects on biomechanics on people who have had an anterior cruciate ligament reconstruction and healthy controls

Conditions

  • Anterior Cruciate Ligament Tear

Interventions

DEVICE

Blood flow restriction

Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • University of Washington

    lead OTHER

Principal Investigators

  • Scott Telfer, EngD · University of Washington

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-08
Primary Completion
2020-11-02
Completion
2020-11-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04635579 on ClinicalTrials.gov